Publicacións nas que colabora con Marisol Ucha Samartín (17)

2022

  1. Switching between reference adalimumab and biosimilars in chronic immune-mediated inflammatory diseases: A systematic literature review

    British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1529-1550

2021

  1. Direct costs in patients with chronic inflammatory arthropathies on biological therapy: A real-world data study

    Clinical and Experimental Rheumatology, Vol. 39, Núm. 4, pp. 736-745

  2. Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E47-E50

  3. Real-world prevalence and consequences of potential drug-drug interactions in the first-wave COVID-19 treatments

    Journal of Clinical Pharmacy and Therapeutics, Vol. 46, Núm. 3, pp. 724-730

2020

  1. Metodología Lean: diseño y evaluación de un modelo estandarizado de almacenaje de medicación

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 1, pp. 3-9

2019

  1. Adherence to biological therapies in patients with chronic inflammatory arthropathies

    Farmacia Hospitalaria, Vol. 43, Núm. 4, pp. 134-139

  2. Content analysis of Twitter in relation to biological treatments for chronic inflammatory arthropathies: An exploratory study

    European Journal of Hospital Pharmacy , Vol. 26, Núm. 3, pp. 124-128

  3. Devising of a risk map on the management of high risk alert medication in a high level university hospital

    Farmacia Hospitalaria, Vol. 43, Núm. 3, pp. 110-115

  4. Model of teleconsultation pharmaceutical integrated in the electronic clinical history of the patient

    Farmacia Hospitalaria, Vol. 43, Núm. 1, pp. 1-5

2018

  1. Factors associated with patient satisfaction in an outpatient hospital pharmacy

    European Journal of Hospital Pharmacy , Vol. 25, Núm. 4, pp. 183-188

  2. Pharmacotherapeutic Reports as Tools for Detecting Discrepancies in Continuity of Care

    Therapeutic Innovation and Regulatory Science, Vol. 52, Núm. 1, pp. 94-99

2016

  1. Multidisciplinary teams involved: Detection of drug-related problems through continuity of care

    Farmacia Hospitalaria, Vol. 40, Núm. 6, pp. 529-543

2014

  1. Intervencionesfarmaceúticas relacionadas con la prevención de errores de medicacíon en la transićion asistencial de pacientes tratados con apomorfina

    Farmacia Hospitalaria, Vol. 38, Núm. 3, pp. 227-230

  2. Medication non- adherence as a cause of hospital admissions

    Farmacia Hospitalaria, Vol. 38, Núm. 4, pp. 328-333

2013

  1. Impacto económico de la resolución de problemas relacionados con medicamentos en un servicio de urgencias

    Farmacia Hospitalaria, Vol. 37, Núm. 1, pp. 59-64

2012

  1. Contención del gasto farmacéutico en un servicio de urgencia

    Revista de calidad asistencial, Vol. 27, Núm. 5, pp. 298-299

2011

  1. Cellulase in the treatment of phytobezoars

    Nutricion Hospitalaria, Vol. 26, Núm. 6, pp. 1490